GIRARD, L. P. Glucagon-like Peptide Receptor Agonists (GLP-1 receptor agonists): A Powerful Addition to Foundational Therapy Kidney Care in Patients with Type 2 Diabetes Mellitus. Canadian Diabetes & Endocrinology Today, [S. l.], v. 2, n. 3, p. 33–37, 2024. DOI: 10.58931/cdet.2024.2333. Disponível em: https://CanadianDiabetesAndEndocrinologyToday.com/article/view/2-3-Girard. Acesso em: 4 dec. 2024.